Mutation pattern of lamivudine resistance in relation to hepatitis B genotypes: Hepatitis B genotypes differ in their lamivudine resistance associated mutation pattern-Reference-Cited by-同舟云学术

Mutation pattern of lamivudine resistance in relation to hepatitis B genotypes: Hepatitis B genotypes differ in their lamivudine resistance associated mutation pattern

Published:2010-09-17 Issue:11 Volume:82 Page:1850-1858
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J. Med. Virol.

Author:

Damerow Hans,Yuen Lilly,Wiegand Johannes,Walker Christine,Bock C.-Thomas,Locarnini Stephen,Tillmann Hans L.

Publisher

Wiley

Subject

Infectious Diseases,Virology

Reference40 articles.

1. Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy: Characterization of genotype G in Brazil;Bottecchia;BMC Microbiol,2008

2. YSDD: A novel mutation in HBV DNA polymerase confers clinical resistance to lamivudine;Bozdayi;J Viral Hepat,2003

3. Modeling the cost-effectiveness of different oral antiviral therapies in patients with chronic hepatitis B;Buti;J Hepatol,2009

4. Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: The German guidelines for the management of HBV infection;Cornberg;Z Gastroenterol,2007

5. The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro;Delaney;J Virol,2003

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detection and Genetic Characterization of Hepatitis B and D Viruses: A Multi-Site Cross-Sectional Study of People Who Use Illicit Drugs in the Amazon Region;Viruses;2021-07-15

2. Next-generation sequencing for the diagnosis of hepatitis B: current status and future prospects;Expert Review of Molecular Diagnostics;2021-04-03

3. Viral Hepatit B Hastalarında İlk Tedavi Öncesi Revers Transkriptaz İnhibitörü Nükleozid Analoğu İlaç Direnç Profilinin Belirlenmesi;Mikrobiyoloji Bulteni;2019-04-15

4. Current state-of-the-art pharmacotherapy for the management of hepatitis B infection;Expert Opinion on Pharmacotherapy;2019-03-11

5. Assembly Properties of Hepatitis B Virus Core Protein Mutants Correlate with Their Resistance to Assembly-Directed Antivirals;Journal of Virology;2018-10-15